Found 21 matching trials
Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma
PHASE2Primary central nervous system diffuse large B-cell lymphoma (PCNSL-DLBCL) ...
Location
Beijing Tongren Hospital, Capital Medical University
MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal Cancer
PHASE2To further validate the performance of the high-sensitivity MRD assay in pa...
Location
Cancer hospital, CAMS
Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL
PHASE1This research study is studying if the investigational drug, Pembrolizumab,...
Location
Brigham and Women's Hospital
Association Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLC
N/AThis study will investigate the relationship between respiratory and gut mi...
Location
Multiple Locations
Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC
PHASE2This is a single-center, single-arm, phase II clinical study to evaluate th...
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Sequential Intranodal Immunotherapy (SIIT) Combined With Anti-PD1 (Pembrolizumab) in Follicular Lymphoma
PHASE2Follicular lymphoma (FL) is the most common subtype of indolent non-Hodgkin...
Location
Oslo University Hospital Radiumhospitalet
Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma
PHASE2The investigators hypothesize that the addition of Tislelizumab after defin...
Location
Rutgers Cancer Institute of New Jersey
Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients
PHASE2This study is a multi-center, Single-arm Phase II study to evaluate the cli...
Location
Jiamusi Cancer Hospital
Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma
PHASE2The choice of the best second-line therapy in patients with high LH R/R ris...
Location
Hospital Regional Alta Especialidad Bajio
DA-EPOCH-R Induction Followed by Nivolumab Consolidation in Newly Diagnosed MYC, BCL2 and/or BCL6 Rearranged HGBL
PHASE2The prognosis of patients with "high-grade B cell lymphoma with cellular my...
Status
Active Not Recruiting
Location
BE-Antwerpen-ZNASTUIVENBERG